Which has higher earnings and valuation, BVXP or BXP?

Beximco Pharmaceuticals has higher revenue and earnings than Bioventix. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bioventix £12.54M 6.15 £8.12M £140.52 10.51 Beximco Pharmaceuticals £53.93B 0.00 £970.84B £1.94 thousand 0.03

Does the media refer more to BVXP or BXP?

In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than Bioventix. MarketBeat recorded 2 mentions for Beximco Pharmaceuticals and 1 mentions for Bioventix. Bioventix's average media sentiment score of 0.75 beat Beximco Pharmaceuticals' score of 0.37 indicating that Bioventix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bioventix 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beximco Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, BVXP or ANCR?

Animalcare Group has higher revenue and earnings than Bioventix. Bioventix is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bioventix £12.54M 6.15 £8.12M £140.52 10.51 Animalcare Group £89.11M 2.60 £36.55M £7.30 45.89

Does the media prefer BVXP or VLG?

In the previous week, Bioventix and Bioventix both had 1 articles in the media. Venture Life Group's average media sentiment score of 1.11 beat Bioventix's score of 0.75 indicating that Venture Life Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bioventix 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Venture Life Group 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, BVXP or ORPH?

Bioventix has higher earnings, but lower revenue than Open Orphan. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bioventix £12.54M 6.15 £8.12M £140.52 10.51 Open Orphan £34.71M 0.00 N/A N/A N/A

Does the media prefer BVXP or ORPH?

In the previous week, Bioventix and Bioventix both had 1 articles in the media. Bioventix's average media sentiment score of 0.75 beat Open Orphan's score of 0.00 indicating that Bioventix is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bioventix 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Open Orphan 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Bioventix (BVXP) Competitors

GBX 1,477 -33.00 (-2.19%)

As of 09/15/2026 12:14 PM Eastern

Compare

BVXP vs. AGY, BXP, ANCR, VLG, and ORPH

Should you buy Bioventix stock or one of its competitors? Bioventix's main competitors and comparable companies include Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), Animalcare Group (ANCR), Venture Life Group (VLG), and Open Orphan (ORPH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Bioventix compare to Allergy Therapeutics?

Allergy Therapeutics (LON:AGY) and Bioventix (LON:BVXP) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability.

Bioventix has a net margin of 59.30% compared to Allergy Therapeutics' net margin of -85.46%. Allergy Therapeutics' return on equity of 409.00% beat Bioventix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Allergy Therapeutics	-85.46%	409.00%	-34.76%
Bioventix	59.30%	65.83%	54.07%

0.0% of Allergy Therapeutics shares are held by institutional investors. Comparatively, 20.6% of Bioventix shares are held by institutional investors. 3.6% of Allergy Therapeutics shares are held by insiders. Comparatively, 6.2% of Bioventix shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Bioventix had 1 more articles in the media than Allergy Therapeutics. MarketBeat recorded 1 mentions for Bioventix and 0 mentions for Allergy Therapeutics. Bioventix's average media sentiment score of 0.75 beat Allergy Therapeutics' score of 0.00 indicating that Bioventix is being referred to more favorably in the news media.

Company	Overall Sentiment
Allergy Therapeutics	Neutral
Bioventix	Positive

Allergy Therapeutics has a beta of 0.835, indicating that its share price is 17% less volatile than the broader market. Comparatively, Bioventix has a beta of 0.555, indicating that its share price is 45% less volatile than the broader market.

Bioventix has lower revenue, but higher earnings than Allergy Therapeutics. Allergy Therapeutics is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Allergy Therapeutics	£57.29M	5.53	-£52.59M	-£0.97	N/A
Bioventix	£12.54M	6.15	£8.12M	£140.52	10.51

Summary

Bioventix beats Allergy Therapeutics on 10 of the 13 factors compared between the two stocks.

How does Bioventix compare to Beximco Pharmaceuticals?

Bioventix (LON:BVXP) and Beximco Pharmaceuticals (LON:BXP) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, earnings, dividends, media sentiment, risk and analyst recommendations.

Beximco Pharmaceuticals has higher revenue and earnings than Bioventix. Beximco Pharmaceuticals is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventix	£12.54M	6.15	£8.12M	£140.52	10.51
Beximco Pharmaceuticals	£53.93B	0.00	£970.84B	£1.94 thousand	0.03

In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than Bioventix. MarketBeat recorded 2 mentions for Beximco Pharmaceuticals and 1 mentions for Bioventix. Bioventix's average media sentiment score of 0.75 beat Beximco Pharmaceuticals' score of 0.37 indicating that Bioventix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bioventix	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Beximco Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Bioventix has a beta of 0.555, indicating that its stock price is 45% less volatile than the broader market. Comparatively, Beximco Pharmaceuticals has a beta of 0.248, indicating that its stock price is 75% less volatile than the broader market.

Bioventix has a net margin of 59.30% compared to Beximco Pharmaceuticals' net margin of 16.76%. Bioventix's return on equity of 65.83% beat Beximco Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventix	59.30%	65.83%	54.07%
Beximco Pharmaceuticals	16.76%	11.99%	6.97%

20.6% of Bioventix shares are held by institutional investors. Comparatively, 0.3% of Beximco Pharmaceuticals shares are held by institutional investors. 6.2% of Bioventix shares are held by company insiders. Comparatively, 4.2% of Beximco Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Bioventix beats Beximco Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

How does Bioventix compare to Animalcare Group?

Bioventix (LON:BVXP) and Animalcare Group (LON:ANCR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation.

In the previous week, Bioventix had 1 more articles in the media than Animalcare Group. MarketBeat recorded 1 mentions for Bioventix and 0 mentions for Animalcare Group. Bioventix's average media sentiment score of 0.75 beat Animalcare Group's score of 0.00 indicating that Bioventix is being referred to more favorably in the media.

Company	Overall Sentiment
Bioventix	Positive
Animalcare Group	Neutral

20.6% of Bioventix shares are held by institutional investors. Comparatively, 14.3% of Animalcare Group shares are held by institutional investors. 6.2% of Bioventix shares are held by insiders. Comparatively, 30.1% of Animalcare Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Bioventix has a net margin of 59.30% compared to Animalcare Group's net margin of 5.70%. Bioventix's return on equity of 65.83% beat Animalcare Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventix	59.30%	65.83%	54.07%
Animalcare Group	5.70%	4.46%	2.97%

Bioventix pays an annual dividend of GBX 150 per share and has a dividend yield of 10.2%. Animalcare Group pays an annual dividend of GBX 5.20 per share and has a dividend yield of 1.6%. Bioventix pays out 106.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Animalcare Group pays out 71.2% of its earnings in the form of a dividend.

Bioventix has a beta of 0.555, indicating that its stock price is 45% less volatile than the broader market. Comparatively, Animalcare Group has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

Animalcare Group has higher revenue and earnings than Bioventix. Bioventix is trading at a lower price-to-earnings ratio than Animalcare Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventix	£12.54M	6.15	£8.12M	£140.52	10.51
Animalcare Group	£89.11M	2.60	£36.55M	£7.30	45.89

Summary

Bioventix beats Animalcare Group on 9 of the 15 factors compared between the two stocks.

How does Bioventix compare to Venture Life Group?

Bioventix (LON:BVXP) and Venture Life Group (LON:VLG) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, risk, profitability, dividends, valuation, institutional ownership and earnings.

In the previous week, Bioventix and Bioventix both had 1 articles in the media. Venture Life Group's average media sentiment score of 1.11 beat Bioventix's score of 0.75 indicating that Venture Life Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bioventix	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Venture Life Group	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bioventix has a beta of 0.555, indicating that its stock price is 45% less volatile than the broader market. Comparatively, Venture Life Group has a beta of 0.234, indicating that its stock price is 77% less volatile than the broader market.

20.6% of Bioventix shares are owned by institutional investors. Comparatively, 21.9% of Venture Life Group shares are owned by institutional investors. 6.2% of Bioventix shares are owned by insiders. Comparatively, 7.5% of Venture Life Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Bioventix has a net margin of 59.30% compared to Venture Life Group's net margin of 17.42%. Bioventix's return on equity of 65.83% beat Venture Life Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventix	59.30%	65.83%	54.07%
Venture Life Group	17.42%	7.82%	1.56%

Bioventix has higher earnings, but lower revenue than Venture Life Group. Bioventix is trading at a lower price-to-earnings ratio than Venture Life Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventix	£12.54M	6.15	£8.12M	£140.52	10.51
Venture Life Group	£35.17M	2.36	£747.21K	£4.37	15.79

Summary

Bioventix beats Venture Life Group on 7 of the 12 factors compared between the two stocks.

How does Bioventix compare to Open Orphan?

Bioventix (LON:BVXP) and Open Orphan (LON:ORPH) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

Bioventix has higher earnings, but lower revenue than Open Orphan.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bioventix	£12.54M	6.15	£8.12M	£140.52	10.51
Open Orphan	£34.71M	0.00	N/A	N/A	N/A

Bioventix has a net margin of 59.30% compared to Open Orphan's net margin of 0.00%. Bioventix's return on equity of 65.83% beat Open Orphan's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bioventix	59.30%	65.83%	54.07%
Open Orphan	N/A	N/A	N/A

In the previous week, Bioventix and Bioventix both had 1 articles in the media. Bioventix's average media sentiment score of 0.75 beat Open Orphan's score of 0.00 indicating that Bioventix is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bioventix	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Open Orphan	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

20.6% of Bioventix shares are held by institutional investors. 6.2% of Bioventix shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Bioventix beats Open Orphan on 7 of the 8 factors compared between the two stocks.

Get Bioventix News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BVXP vs. The Competition

Export

Metric	Bioventix	Pharmaceuticals Industry	Healthcare Sector	LON Exchange
Market Cap	£77.17M	£12.43B	£7.21B	£2.88B
Dividend Yield	9.38%	2.63%	2.57%	6.26%
P/E Ratio	10.51	789.61	272.84	366.92
Price / Sales	6.15	952.99	701.69	90,001.88
Price / Cash	30.89	89.50	77.71	27.89
Price / Book	6.42	10.41	10.37	6.33
Net Income	£8.12M	£2.83B	£3.49B	£5.89B
7 Day Performance	-8.83%	-1.51%	-0.76%	-0.36%
1 Month Performance	-3.97%	0.80%	-0.39%	-0.68%
1 Year Performance	-39.57%	3.96%	18.93%	19.86%

Bioventix Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BVXP Bioventix	N/A	GBX 1,477 -2.2%	N/A	-40.9%	£77.17M	£12.54M	10.51	12	High Trading Volume
AGY Allergy Therapeutics	N/A	GBX 5 +5.3%	N/A	-39.8%	£316.63M	£57.29M	N/A	612	Gap Down
BXP Beximco Pharmaceuticals	N/A	GBX 60 -4.0%	N/A	+26.6%	£267.67M	£53.93B	0.03	5,500	News Coverage
ANCR Animalcare Group	N/A	GBX 335 flat	N/A	N/A	£231.30M	£89.11M	45.89	220
VLG Venture Life Group	N/A	GBX 67.90 +1.8%	N/A	+21.1%	£81.51M	£35.17M	15.54	165	News Coverage

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:BVXP) was last updated on 9/16/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Bioventix (BVXP) Competitors

BVXP vs. AGY, BXP, ANCR, VLG, and ORPH

How does Bioventix compare to Allergy Therapeutics?

Summary

How does Bioventix compare to Beximco Pharmaceuticals?

Summary

How does Bioventix compare to Animalcare Group?

Summary

How does Bioventix compare to Venture Life Group?

Summary

How does Bioventix compare to Open Orphan?

Summary

Media Sentiment Over Time

BVXP vs. The Competition

Bioventix Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Bioventix (BVXP) Competitors

BVXP vs. AGY, BXP, ANCR, VLG, and ORPH

How does Bioventix compare to Allergy Therapeutics?

Is AGY or BVXP more profitable?

Do insiders and institutionals have more ownership in AGY or BVXP?

Does the media favor AGY or BVXP?

Which has more risk and volatility, AGY or BVXP?

Which has better valuation and earnings, AGY or BVXP?

Summary

How does Bioventix compare to Beximco Pharmaceuticals?

Which has higher earnings and valuation, BVXP or BXP?

Does the media refer more to BVXP or BXP?

Which has more risk & volatility, BVXP or BXP?

Is BVXP or BXP more profitable?

Do institutionals & insiders hold more shares of BVXP or BXP?

Summary

How does Bioventix compare to Animalcare Group?

Does the media prefer BVXP or ANCR?

Do institutionals & insiders have more ownership in BVXP or ANCR?

Is BVXP or ANCR more profitable?

Is BVXP or ANCR a better dividend stock?

Which has more volatility & risk, BVXP or ANCR?

Which has preferable valuation and earnings, BVXP or ANCR?

Summary

How does Bioventix compare to Venture Life Group?

Does the media prefer BVXP or VLG?

Which has more volatility & risk, BVXP or VLG?

Do insiders and institutionals have more ownership in BVXP or VLG?

Is BVXP or VLG more profitable?

Which has preferable valuation & earnings, BVXP or VLG?

Summary

How does Bioventix compare to Open Orphan?

Which has preferable valuation and earnings, BVXP or ORPH?

Is BVXP or ORPH more profitable?

Does the media prefer BVXP or ORPH?

Do institutionals & insiders hold more shares of BVXP or ORPH?

Summary

Media Sentiment Over Time

BVXP vs. The Competition

Bioventix Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools